Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 9392404, 11 pages
http://dx.doi.org/10.1155/2016/9392404
Research Article

PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth

Panacea Pharmaceuticals, Inc., 209 Perry Parkway, Suite 13, Gaithersburg, MD 20877, USA

Received 7 April 2015; Revised 2 July 2015; Accepted 6 July 2015

Academic Editor: Swaran J. S. Flora

Copyright © 2016 Zhi-Gang Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. B. Newton, “Neurological complications of chemotherapy to the central nervous system,” Handbook of Clinical Neurology, vol. 105, pp. 903–916, 2012. View at Google Scholar
  2. J. Vardy, S. Rourke, and I. F. Tannock, “Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research,” Journal of Clinical Oncology, vol. 25, no. 17, pp. 2455–2463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Joly, O. Rigal, S. Noal, and B. Giffard, “Cognitive dysfunction and cancer: which consequences in terms of disease management?” Psycho-Oncology, vol. 20, no. 12, pp. 1251–1258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F. S. A. M. van Dam, S. B. Schagen, M. J. Muller et al., “Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy,” Journal of the National Cancer Institute, vol. 90, no. 3, pp. 210–218, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. A. Castellon, P. A. Ganz, J. E. Bower, L. Petersen, L. Abraham, and G. A. Greendale, “Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen,” Journal of Clinical and Experimental Neuropsychology, vol. 26, no. 7, pp. 955–969, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Vardy, J. S. Wefel, T. Ahles, I. F. Tannock, and S. B. Schagen, “Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop,” Annals of Oncology, vol. 19, no. 4, pp. 623–629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Clinic Staffs, “Antioxidant supplementation in cancer: potential interactions with conventional chemotherapy and radiation therapy,” Thomas Jefferson University Hospital, 2014, http://jdc.jefferson.edu/jmbcim/12/.
  8. M. Lamberti, S. Porto, M. Marra et al., “5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress,” Journal of Experimental & Clinical Cancer Research, vol. 31, article 60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Baba, J. I. Sonoda, S. Hayashi et al., “Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy,” Experimental and Therapeutic Medicine, vol. 4, no. 3, pp. 452–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Numazawa, K. Sugihara, S. Miyake et al., “Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice,” Basic & Clinical Pharmacology & Toxicology, vol. 108, no. 1, pp. 40–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. A. Ahles and A. J. Saykin, “Candidate mechanisms for chemotherapy-induced cognitive changes,” Nature Reviews Cancer, vol. 7, no. 3, pp. 192–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Miketova, K. Kaemingk, M. Hockenberry et al., “Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia,” Biological Research for Nursing, vol. 6, no. 3, pp. 187–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Caron, K. R. Krull, M. Hockenberry, N. Jain, K. Kaemingk, and I. M. Moore, “Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia,” Pediatric Blood & Cancer, vol. 53, no. 4, pp. 551–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Pan, C. M. Dancik, V. M. Nelson et al., “A novel neuroprotectant PAN-811 protects neurons from hydrogen peroxide induced cell death,” Central European Journal of Biology, vol. 4, no. 1, pp. 34–40, 2009. View at Google Scholar
  15. V. M. Nelson, C. M. Dancik, W. Pan, Z.-G. Jiang, M. S. Lebowitz, and H. A. Ghanbari, “PAN-811 inhibits oxidative stress-induced cell death of human alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species,” Journal of Alzheimer's Disease, vol. 17, no. 3, pp. 611–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Dehne, J. Lautermann, F. Petrat, U. Rauen, and H. De Groot, “Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals,” Toxicology and Applied Pharmacology, vol. 174, no. 1, pp. 27–34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Jiang, C. Guo, M. R. Vasko, and M. R. Kelley, “Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons,” Cancer Research, vol. 68, no. 15, pp. 6425–6434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. A. G. Santos, C. S. C. Bezerra, N. M. Martins, C. Curti, M. L. P. Bianchi, and A. C. Santos, “Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria,” Cancer Chemotherapy and Pharmacology, vol. 61, no. 1, pp. 145–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Melli, M. Taiana, F. Camozzi et al., “Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy,” Experimental Neurology, vol. 214, no. 2, pp. 276–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. A. El-Beshbishy, S. A. Bahashwan, H. A. A. Aly, and H. A. Fakher, “Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes,” European Journal of Pharmacology, vol. 668, no. 1-2, pp. 278–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Fardell, J. Vardy, I. N. Johnston, and G. Winocur, “Chemotherapy and cognitive impairment: treatment options,” Clinical Pharmacology and Therapeutics, vol. 90, no. 3, pp. 366–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Z.-G. Jiang, X. C. Lu, V. Nelson et al., “A multi-functional cytoprotective agent that can reduce stroke-induced neurodegeneration when administered even after ischemic attack,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1581–1586, 2006. View at Google Scholar
  23. J. Li, O. Wuliji, W. Li, Z.-G. Jiang, and H. A. Ghanbari, “Oxidative stress and neurodegenerative disorders,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 24438–24475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Joshi, S. Hardas, R. Sultana, D. K. St. Clair, M. Vore, and D. A. Butterfield, “Glutathione elevation by γ-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: implication for chemobrain,” Journal of Neuroscience Research, vol. 85, no. 3, pp. 497–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. W. Konat, M. Kraszpulski, I. James, H.-T. Zhang, and J. Abraham, “Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats,” Metabolic Brain Disease, vol. 23, no. 3, pp. 325–333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Z.-G. Jiang, C. Piggee, M. P. Heyes et al., “Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages,” Journal of Neuroimmunology, vol. 117, no. 1-2, pp. 97–107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Csordas, M. Hegyi, O. T. Eipel, J. Muller, D. J. Erdelyi, and G. T. Kovacs, “Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia,” Anti-Cancer Drugs, vol. 24, no. 2, pp. 189–197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Vassal, D. Valteau, M. Bonnay, C. Patte, F. Aubier, and J. Lemerle, “Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma,” Pediatric Hematology and Oncology, vol. 7, no. 1, pp. 71–77, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. S. E. James, H. Burden, R. Burgess et al., “Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants,” NeuroToxicology, vol. 29, no. 4, pp. 605–612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Rzeski, S. Pruskil, A. Macke et al., “Anticancer agents are potent neurotoxins in vitro and in vivo,” Annals of Neurology, vol. 56, no. 3, pp. 351–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. I. G. Kerr, S. Zimm, J. M. Collins, D. O'Neill, and D. G. Poplack, “Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey,” Cancer Research, vol. 44, no. 11, pp. 4929–4932, 1984. View at Google Scholar · View at Scopus
  32. A. D. Paolo, M. Lencioni, F. Amatori et al., “5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer,” Clinical Cancer Research, vol. 14, no. 9, pp. 2749–2755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zhang, L. Zhang, Y. Yan et al., “Are capecitabine and the active metabolite 5-FU CNS penetrable to treat breast cancer brain metastasis?” Drug Metabolism and Disposition, vol. 43, no. 3, pp. 411–417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Scuteri, E. Donzelli, M. Ravasi, and G. Tredici, “Adult mesenchymal stem cells support cisplatin-treated dorsal root ganglion survival,” Neuroscience Letters, vol. 445, no. 1, pp. 68–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Gill and A. J. Windebank, “Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle,” The Journal of Clinical Investigation, vol. 101, no. 12, pp. 2842–2850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Tangpong, M. P. Cole, R. Sultana et al., “Adriamycin-induced, TNF-α-mediated central nervous system toxicity,” Neurobiology of Disease, vol. 23, no. 1, pp. 127–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Ayromlou, B. Hajipour, M. M. Hossenian, A. Khodadadi, and A. M. Vatankhah, “Oxidative effect of methotrexate administration in spinal cord of rabbits,” The Journal of the Pakistan Medical Association, vol. 61, no. 11, pp. 1096–1099, 2011. View at Google Scholar · View at Scopus
  38. J. Kasapović, S. Pejić, V. Stojiljković et al., “Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide,” Clinical Biochemistry, vol. 43, no. 16-17, pp. 1287–1293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Weller, A. M. Marini, F. Finiels-Marlier, B. Martin, and S. M. Paul, “MK-801 and memantine protect cultured neurons from glutamate toxicity induced by glutamate carboxypeptidase-mediated cleavage of methotrexate,” European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 248, no. 4, pp. 303–312, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, supplement 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-M. Lü, P. H. Lin, Q. Yao, and C. Chen, “Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 840–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. T. R. Rajagopalan, Z. Zhang, L. McCourt, M. Dwyer, S. J. Benkovic, and G. G. Hammes, “Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13481–13486, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-Fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Tanida, T. Mizoshita, K. Ozeki et al., “Mechanisms of cisplatin-induced apoptosis and of cisplatin sensitivity: potential of BIN1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment,” International Journal of Surgical Oncology, vol. 2012, Article ID 862879, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. R. A. Finch, M.-C. Liu, A. H. Cory, J. G. Cory, and A. C. Sartorelli, “Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity,” Advances in Enzyme Regulation, vol. 39, pp. 3–12, 1999. View at Publisher · View at Google Scholar · View at Scopus